Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07621081 · ClinicalTrials.gov registry record · NA
Brief Single-Session Body Neutrality Program for LGBTQ+ Adults in Central Alabama
A NA study, sponsored by Auburn University.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07621081: Clinical Trial NA study, sponsored by Auburn University.
NCT07621081 is a NA study that has not yet begun recruiting, run by Auburn University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07621081, a NA study, has not yet begun recruiting, sponsored by Auburn University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
LGBTQ+ individuals tend to have elevated risks for eating disorders (ED), possibly due to minority stress. For LGBTQ+ individuals living in rural Alabama, they tend to experience high levels of anti-LGBTQ+ structural stigma and limited access to LGBTQ+-specific resources, which engender compounded risk for ED development and reduced access to care. Brief digital single-session intervention that incorporates psychoeducation about minority stress and body neutrality may be efficacious in reducing ED risk and improve positive body image among LGBTQ+ adults in rural areas. Prior research from another lab developed a single-session intervention (Project Body Neutrality) among LGBTQ+ adolescents indicated immediate positive changes in body image constructs and psychological well-being. The present project evaluates and adapts Project Body Neutrality, specifically for LGBTQ+ adults in a rural high-stigma, low-resource region.
Primary Outcome
Assesses changes in functionality appreciation (7 items, 7-point scale), with higher scores indicating higher levels of functionality appreciation.
Interventions
- BEHAVIORAL Single session body neutrality program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-08-02 |
| Est. Completion | 2028-08-02 |
| Phase | NA |
What is known before NCT07621081 opens enrollment
NCT07621081 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Single session body neutrality program is the first listed.
NCT07621081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07621081 about?
NCT07621081 is a clinical study titled "Brief Single-Session Body Neutrality Program for LGBTQ+ Adults in Central Alabama". LGBTQ+ individuals tend to have elevated risks for eating disorders (ED), possibly due to minority stress. For LGBTQ+ individuals living in rural Alabama, they tend to experience high levels of anti-LGBTQ+ structural stigma and limited access to LGBTQ+-specific resources, which engender compounded r...
What is the current status of trial NCT07621081?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-08-02. Estimated completion is 2028-08-02.
What interventions are being tested in trial NCT07621081?
The interventions under investigation include: Single session body neutrality program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07621081?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07621081's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI